Serum CRP Is a Better Early Marker for Response to Infliximab Induction Therapy Than Fecal Calprotectin in Patients With Moderate to Severe Ulcerative Colitis

被引：0
|
作者：
Brandse, Johannan F.
Jansen, Jeroen M.
Baars, Paul A.
Lowenberg, M.
Ponsioen, Cyriel
van den Brink, Gijs R.
D'Haens, Geert R.
机构：
来源：
GASTROENTEROLOGY | 2014年 / 146卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
212
引用
收藏
页码：S55 / S56
页数：2
相关论文
共 50 条
  • [41] Predictors of Response to Infliximab As Salvage Therapy for Severe Steroid Refractory Ulcerative Colitis
    Vaughn, Byron P.
    Pleet, Julie
    Cheifetz, Adam S.
    Moss, Alan C.
    GASTROENTEROLOGY, 2013, 144 (05) : S434 - S434
  • [42] Intensified infliximab induction therapy for steroid-refractory acute severe ulcerative colitis
    Coman, Diana
    Battat, Robert
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2025, 10 (01): : 17 - 18
  • [43] Head-to-head comparison of 5 fecal markers to predict response to induction and maintenance therapy with infliximab in ulcerative colitis patients; a prospective study
    Frin, A. C.
    Nancey, S.
    Filippi, J.
    Boschetti, G.
    Flourie, B.
    Drai, J.
    Ferrari, P.
    Hebuterne, X.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S263 - S264
  • [44] Rapid fecal calprotectin testing predicts mucosal healing better than C-reactive protein and serum tumor necrosis factor alpha in patients with ulcerative colitis
    Voiosu, T.
    Bengus, Andreea
    Balanescu, P.
    Dinu, Roxana
    Voiosu, A.
    Baicus, C.
    Mateescu, B.
    ROMANIAN JOURNAL OF INTERNAL MEDICINE, 2015, 53 (03) : 253 - 260
  • [45] Infliximab trough levels are lower in patients with acute severe, compared to moderate-severe ulcerative colitis patients
    Ungar, B.
    Mazor, Y.
    Yanai, H.
    Ron, Y.
    Waizbard, A.
    Yavzori, M.
    Fudim, E.
    Picard, O.
    Loebstein, R.
    Kopylov, U.
    Dotan, I.
    Chowers, Y.
    Eliakim, R.
    Ben-Horin, S.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S314 - S315
  • [46] Early Infliximab Rescue therapy is associated with reduced length of stay in patients with acute severe ulcerative colitis
    Mohamedrashed, M.
    Yogakanthi, S.
    Xu, C.
    Bartlett, R.
    Chew, M.
    Nedumannil, L.
    Lucas, S.
    Chauhan, A.
    Lewis, D.
    Kashkooli, S.
    Garg, M.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1492 - i1493
  • [47] Use of Serum Infliximab Level Prior to Cyclosporine Salvage Therapy in Severe Ulcerative Colitis
    Rubin, David
    Chapman, Christopher
    Bochenek, Ashley
    Stein, Adam
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S423 - S423
  • [48] Use of Serum Infliximab Level Prior to Cyclosporine Salvage Therapy in Severe Ulcerative Colitis
    Chapman, Christopher G.
    Bochenek, Ashley
    Stein, Adam C.
    Rubin, David T.
    ACG CASE REPORTS JOURNAL, 2014, 1 (03): : 148 - 150
  • [49] Fecal calprotectin as an alternative to ulcerative colitis endoscopic index of severity to predict the response to corticosteroids of acute severe ulcerative colitis: A prospective observational study
    Xie, Tingbin
    Zhao, Chenyan
    Ding, Chao
    Zhang, Tenghui
    Dai, Xujie
    Lv, Tengfei
    Li, Yi
    Guo, Zhen
    Gong, Jianfeng
    Zhu, Weiming
    DIGESTIVE AND LIVER DISEASE, 2017, 49 (09) : 984 - 990
  • [50] Predictors of early clinical response to infliximab in 100 patients with ulcerative colitis
    Ferrante, M.
    Vemeire, S.
    Katsanos, K. H.
    Noman, M.
    Van Assche, C.
    De Hertogh, G.
    Hoffman, I.
    Geboes, K.
    Rutgeerts, P.
    ACTA CLINICA BELGICA, 2006, 61 (05): : 299 - 299
12345